Investors & Media

We are driven to develop meaningful therapies for patients while creating value for stockholders.

Investors & Media

Corporate Profile

We are a biopharmaceutical company on a mission to develop treatments for serious diseases.

Press Releases

Dec 17, 2024

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Aug 07, 2024

Regina Graul, Ph.D., Promoted to Chief Executive Officer

Dec 04, 2023

Cyclerion Appoints Regina Graul, Ph.D., as President

Nov 30, 2023

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

view all

Stock Quote

Change
Volume
52 Week High
52 Week Low

Minimum 15 minutes delayed. Source: LSEG

Top